Effect of gene constellation and postreassortment amino acid change on the phenotypic features of H5 influenza virus reassortants

Archives of Virology

Volumn 152, Issue 6, 2007, Pages 1139-1145

  Rudneva, I A ^a   Timofeeva, T A ^a   Shilov, A A ^a   Kochergin Nikitsky, K S ^a   Varich, N L ^a   Ilyushina, N A ^a   Gambaryan, A S ^b   Krylov, P S ^a   Kaverin, N V ^a  

^a D I IVANOVSKY INSTITUTE OF VIROLOGY   (Russian Federation)

^b CHUMAKOV INSTITUTE OF POLIOMYELITIS AND VIRAL ENCEPHALITIDES   (Russian Federation)

Author keywords

[No Author keywords available]

Indexed keywords

INFLUENZA VIRUS HEMAGGLUTININ;

AMINO ACID SEQUENCE; ANIMAL; ARTICLE; CHICK EMBRYO; FEMALE; GENETIC REASSORTMENT; GENETIC RECOMBINATION; GENETICS; HUMAN; IMMUNOLOGY; INFLUENZA VIRUS A H1N1; INFLUENZA VIRUS A H5N1; INFLUENZA VIRUS A H5N2; MOUSE; PATHOGENICITY; PHENOTYPE; VIRULENCE; VIRUS GENE;

AMINO ACID SEQUENCE; ANIMALS; CHICK EMBRYO; FEMALE; GENES, VIRAL; HEMAGGLUTININ GLYCOPROTEINS, INFLUENZA VIRUS; HUMANS; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA A VIRUS, H5N1 SUBTYPE; INFLUENZA A VIRUS, H5N2 SUBTYPE; MICE; PHENOTYPE; REASSORTANT VIRUSES; RECOMBINATION, GENETIC; VIRULENCE;

AVES; AVIAN INFLUENZA VIRUS; HUMAN INFLUENZA VIRUS; MUS; ORTHOMYXOVIRIDAE;

EID: 34249031308     PISSN: 03048608     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00705-006-0931-8     Document Type: Article

References (18)

1. Hoffmann E, Lipatov AS, Webby RJ, Govorkova EA, Webster RG (2005) Role of specific hemagglutinin amino acids in the immunogenicity and protection of H5N1 influenza virus vaccines. Proc Natl Acad Sci USA 102: 12915-12920
2. Kaverin NV, Rudneva IA, Smirnov YA, Finskaya NN (1988) Human-avian influenza virus reassortants: effect of reassortment pattern on multi-cycle reproduction in MDCK cells. Arch Virol 103: 117-126
3. Kaverin NV, Gambaryan AS, Bovin NV, Rudneva IA, Shilov AA, Khodova OM, Varich NL, Sinitsin BV, Makarova NV, Kropotkina EA (1998) Postreassortment changes in influenza A virus hemagglutinin restoring HA-NA functional match. Virology 244: 315-321
4. Kaverin NV, Matrosovich MN, Gambaryan AS, Rudneva IA, Shilov AA, Varich NL, Makarova NV, Kropotkina EA, Sinitsin BV (2000) Intergenic HA-NA interactions in influenza A virus: postreassortment substitutions of charged amino acid in the hemagglutinin of different subtypes. Virus Res 66: 123-129
5. Kilbourne ED (2004) Influenza pandemics: can we predict for the unpredictable? Viral Immunol 17: 350-357
6. Lee CW, Senne DA, Suarez DL (2004) Generation of reassortant influenza vaccines by reverse genetics that allows utilization of DIVA (differentiating infected from vaccinated animals strategy for the control of avian influenza. Vaccine 22: 3175-3181
7. Lipatov AS, Govorkova EA, Webby AJ, Ozaki H, Peiris M, Guan Y, Poon L, Webster RG (2004) Influenza: emergence and control. J Virol 78: 8951-8959
8. Liu M, Wood JM, Ellis T, Krauss S, Seiler P, Johnson C, Hoffman E, Humberd J, Hulse D, Zhang Y, Webster RG, Perez DR (2003) Preparation of a standardized, efficacious agricultural H5N3 vaccine by reverse genetics. Virology 314: 580-590
9. Lvov DK, Yamnikova SS, Fedyakina IT et al. (2004) Ecology and evolution of influenza viruses in Russia. Probl Virol 49, #3: 17-24 (Rus)
10. Nicholson KG, Colegate AE, Podda A, Stephenson I, Wood J, Ypma E, Zambon MC (2001) Safety and antigenicity of non-adjuvanted and MF59-adjuvanted influenza A/Duck/Singapore/97 (H5N3) vaccine: a randomized trial of two potential vaccines against H5N1 influenza. Lancet 357: 1937-1943
11. Nicolson C, Major D, Wood JM, Robertson JS (2005) Generation of influenza vaccine viruses on Vero cells by reverse genetics: an H5N1 candidate vaccine strain produced under a quality system. Vaccine 23: 2943-2952
12. Reed LJ, Muench H (1938) A simple method for estimating 50% endpoints. Am J Hyg 27: 493-497
13. Schulman JL, Palese P (1976) Selection and identification of influenza virus recombinants of defined genetic composition. J Virol 20: 248-254
14. Subarrao K, Chen H, Swayne D, Mingay L, Fodor E, Brownlee G, Xu X, Lu X, Katz J, Cox N, Matsuoka Y (2003) Evaluation of a genetically modified reassortant H5N1 influenza virus vaccine candidate generated by plasmid-based reverse genetics. Virology 305: 192-200
15. Takada A, Kuboki N, Okazaki K, Ninomiya A, Tanaka H, Ozaki H, Itamura S, Nishimura H, Enami M, Tashiro M, Shortridge KF, Kida H (1999) Avirulent avian influenza virus as a vaccine strain against a potential human pandemic. J Virol 73: 8303-8307
16. Tian G, Zhang S, Li Y, Bu Z, Liu P, Zhou J, Li C, Shi J, Yu K, Chen H (2005) Protective efficacy in chickens, geese and ducks of an H5N1-inactivated vaccine developed by reverse genetics. Virology 341: 153-162
17. Webby RJ, Perez DR, Coleman JS et al. (2004) Responsiveness to a pandemic alert: use of reverse genetics for rapid development of influenza vaccines. Lancet 363: 1099-1103
18. Webster RG, Bean WJ, Gorman OT, Chambers TM, Kawaoka Y (1992) Evolution and ecology of influenza A viruses. Microbiol Rev 56: 152-179